{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:55:12Z","timestamp":1776326112425,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Research Programme for Universities (NRPU), the Higher Education Commission of Pakistan","award":["17231"],"award-info":[{"award-number":["17231"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42902-4","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:24:31Z","timestamp":1772871871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacogenetics of RAS-affecting AGT and ACE variants and the efficacy of Valsartan\/HCTZ therapy"],"prefix":"10.1038","volume":"16","author":[{"given":"Alija","family":"Baig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muhammad Mukarram","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9488-0516","authenticated-orcid":false,"given":"Abdulrahman Saad","family":"Alfaiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-7253","authenticated-orcid":false,"given":"Muath A.","family":"Alammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3185-6648","authenticated-orcid":false,"given":"Mohammad Dhuwayhi Ghazi","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdur","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiman","family":"Begum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zia Ul","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noorulain","family":"Ainy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2325-9609","authenticated-orcid":false,"given":"Wahby Mohammed","family":"Babaresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Zakiullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"42902_CR1","unstructured":"World Health Organization,. Global report on hypertension: the rACE against a silent killer. (World Health Organization, 2023) (2023)."},{"key":"42902_CR2","doi-asserted-by":"publisher","first-page":"e0246085","DOI":"10.1371\/journal.pone.0246085","volume":"16","author":"M Riaz","year":"2021","unstructured":"Riaz, M. et al. Factors associated with hypertension in Pakistan: A systematic review and meta-analysis. PloS one. 16, e0246085 (2021).","journal-title":"PloS one"},{"key":"42902_CR3","first-page":"79","volume":"14","author":"MU Hassan","year":"2022","unstructured":"Hassan, M. U. et al. Prevalence of hypertension and other associated factors among individuals aging 15 years and above, in federally administered tribal areas of Pakistan. Khyber Med. Univ. J. 14, 79\u201385 (2022).","journal-title":"Khyber Med. Univ. J."},{"key":"42902_CR4","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/s41440-025-02312-x","volume":"48","author":"MG Bellicini","year":"2025","unstructured":"Bellicini, M. G. Hypertensive heart disease: is it really a pathology? Hypertens. Res. 48, 2737\u20132739 (2025).","journal-title":"Hypertens. Res."},{"key":"42902_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1524-6175.2007.06415.x","volume":"9","author":"MR Weir","year":"2007","unstructured":"Weir, M. R. et al. Evaluation of the dose response with valsartan and valsartan\/hydrochlorothiazide in patients with essential hypertension. J. Clin. Hypertens. 9, 103\u2013112 (2007).","journal-title":"J. Clin. Hypertens."},{"key":"42902_CR6","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.3390\/ijms21134709","volume":"21","author":"J Rysz","year":"2020","unstructured":"Rysz, J., Franczyk, B., Rysz-G\u00f3rzy\u0144ska, M. & Gluba-Brz\u00f3zka, A. Pharmacogenomics of hypertension treatment. Int. J. Mol. Sci. 21, 4709 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"42902_CR7","doi-asserted-by":"publisher","first-page":"e003736","DOI":"10.1161\/JAHA.116.003736","volume":"5","author":"P Castiglioni","year":"2016","unstructured":"Castiglioni, P. et al. Hemodynamic and autonomic response to different salt intakes in normotensive individuals. J. Am. Heart Association. 5, e003736 (2016).","journal-title":"J. Am. Heart Association"},{"key":"42902_CR8","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/HYPERTENSIONAHA.123.21369","volume":"81","author":"M Nishimoto","year":"2024","unstructured":"Nishimoto, M., Griffin, K. A., Wynne, B. M. & Fujita, T. Salt-sensitive hypertension and the kidney. Hypertension 81, 1206\u20131217 (2024).","journal-title":"Hypertension"},{"key":"42902_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2165\/00129785-200404030-00002","volume":"4","author":"GL Schwartz","year":"2004","unstructured":"Schwartz, G. L. & Turner, S. T. Pharmacogenetics of antihypertensive drug responses. Am. J. Pharmacogenomics. 4, 151\u2013160 (2004).","journal-title":"Am. J. Pharmacogenomics"},{"key":"42902_CR10","first-page":"341","volume":"12","author":"GH Oliveira-Paula","year":"2019","unstructured":"Oliveira-Paula, G. H., Pereira, S. C., Tanus-Santos, J. E. & Lacchini, R. Pharmacogenomics and hypertension: current insights. Pharmacogenomics Pers. Med. 12, 341\u2013359 (2019).","journal-title":"Pharmacogenomics Pers. Med."},{"key":"42902_CR11","first-page":"351","volume":"20","author":"Y Zhou","year":"2007","unstructured":"Zhou, Y. et al. Possible association of ACE gene I\/D polymorphism with blood pressure-lowering response to hydrochlorothiazide. Biomed. Environ. Sci. 20, 351 (2007).","journal-title":"Biomed. Environ. Sci."},{"key":"42902_CR12","doi-asserted-by":"publisher","first-page":"e70611","DOI":"10.1002\/hsr2.70611","volume":"8","author":"H Alhawari","year":"2025","unstructured":"Alhawari, H. et al. Variability in Response to Valsartan and Its Relationship With AGT M235T Genotype and Other Nongenetic Parameters Among a Sample of Hypertensive Individuals in Jordan: A Prospective Pilot Study. Health Sci. Rep. 8, e70611 (2025).","journal-title":"Health Sci. Rep."},{"key":"42902_CR13","first-page":"624","volume":"70","author":"M Hussain","year":"2020","unstructured":"Hussain, M., Bilal, A. & Awan, F. R. Pharmacogenetic study of ACE, AGT, CYP11B1, CYP11B2 and eNOS gene variants in hypertensive patients from Faisalabad. Pakistan JPMA. 70, 624\u2013629 (2020).","journal-title":"Pakistan JPMA"},{"key":"42902_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/HJH.0b013e328341d117","volume":"29","author":"JJ Brugts","year":"2011","unstructured":"Brugts, J. J. et al. A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals. J. Hypertens. 29, 509\u2013519 (2011).","journal-title":"J. Hypertens."},{"key":"42902_CR15","doi-asserted-by":"publisher","first-page":"147032031982720","DOI":"10.1177\/1470320319827205","volume":"20","author":"HT Gong","year":"2019","unstructured":"Gong, H. T. et al. Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese. J. Renin-Angiotensin-Aldosterone Syst. 20, 1470320319827205 (2019).","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"42902_CR16","doi-asserted-by":"publisher","first-page":"e1004465","DOI":"10.1371\/journal.pmed.1004465","volume":"21","author":"PJ Baptiste","year":"2024","unstructured":"Baptiste, P. J. et al. Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked data. PLoS Med. 21, e1004465 (2024).","journal-title":"PLoS Med."},{"key":"42902_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41371-022-00765-y","volume":"37","author":"SWY Tang","year":"2023","unstructured":"Tang, S. W. Y. et al. The clinical impact of anti-hypertensive treatment drug-gene pairs in the asian population: a systematic review of publications in the past decade. J. Hum. Hypertens. 37, 170\u2013180 (2023).","journal-title":"J. Hum. Hypertens."},{"key":"42902_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s40615-020-00853-0","volume":"8","author":"R Sarangarajan","year":"2021","unstructured":"Sarangarajan, R. et al. Ethnic prevalence of angiotensin-converting enzyme deletion (D) polymorphism and COVID-19 risk: rationale for use of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers. J. Racial Ethnic Health Disparities. 8, 973\u2013980 (2021).","journal-title":"J. Racial Ethnic Health Disparities"},{"key":"42902_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1470320311430991","volume":"13","author":"B Xi","year":"2012","unstructured":"Xi, B., Shen, Y., Yan, Y. & Mi, J. Association of polymorphisms in the AGT gene with essential hypertension in the Chinese population. J. Renin-Angiotensin-Aldosterone Syst. 13, 282\u2013288 (2012).","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"42902_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1741-7015-11-141","volume":"11","author":"LM Brewster","year":"2013","unstructured":"Brewster, L. M. & Seedat, Y. K. Why do hypertensive patients of African ancestry respond better to calciumblockers and diuretics than to ACE inhibitors and \u03b2-adrenergic blockers? Asystematic review. BMC Med. 11, 141 (2013).","journal-title":"BMC Med."},{"key":"42902_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/1060028018779082","volume":"52","author":"A Helmer","year":"2018","unstructured":"Helmer, A., Slater, N. & Smithgall, S. A review of ACE inhibitors and ARBs in black patients with hypertension. Ann. Pharmacother. 52, 1143\u20131151 (2018).","journal-title":"Ann. Pharmacother."},{"key":"42902_CR22","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia Chairperson","year":"2023","unstructured":"Mancia Chairperson, G. et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J. Hypertens. 41, 1874\u20132071 (2023).","journal-title":"J. Hypertens."},{"key":"42902_CR23","first-page":"173","volume":"7","author":"Y Moharamzad","year":"2014","unstructured":"Moharamzad, Y. et al. Validation of the Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Iranian hypertensive patients. Global J. health Sci. 7, 173 (2014).","journal-title":"Global J. health Sci."},{"key":"42902_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fphar.2019.00822","volume":"10","author":"S Shi","year":"2019","unstructured":"Shi, S. et al. Association between medication literacy and medication adherence among patients with hypertension. Front. Pharmacol. 10, 822 (2019).","journal-title":"Front. Pharmacol."},{"key":"42902_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/gepi.20410","volume":"33","author":"J Little","year":"2009","unstructured":"Little, J. et al. STrengthening the REporting of Genetic Association Studies (STREGA)\u2014an extension of the STROBE statement. Genet. Epidemiol. 33, 581\u2013598 (2009).","journal-title":"Genet. Epidemiol."},{"key":"42902_CR26","doi-asserted-by":"crossref","unstructured":"Gong, H. T. et al. Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese. J Renin Angiotensin Aldosterone Syst 20. (2019).","DOI":"10.1177\/1470320319827205"},{"key":"42902_CR27","doi-asserted-by":"crossref","unstructured":"Isordia-Salas, I., Santiago-Germ\u00e1n, D. & Jim\u00e9nez-Alvarado, R. M. and A. Lea\u00f1os-Miranda, Genetic variants associated with high susceptibility of premature ischemic stroke. J. Renin Angiotensin Aldosterone Syst. (2023) (2023).","DOI":"10.1155\/2023\/9002021"},{"key":"42902_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1056\/NEJM199503163321103","volume":"332","author":"K Lindpaintner","year":"1995","unstructured":"Lindpaintner, K. et al. A prospective evaluation of an angiotensin-converting\u2013enzyme gene polymorphism and the risk of ischemic heart disease. N Engl. J. Med. 332, 706\u2013712 (1995).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42902-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42902-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42902-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:18:17Z","timestamp":1776323897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42902-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42902"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42902-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was reviewed and approved by the Ethical Review Board of Lady Reading Hospital, Medical Teaching Institution, Peshawar (Reference No.\n                      92\/LRH\/MTI\n                      , dated\n                      22 March 2021\n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided written informed consent before enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"12504"}}